Potential of Comprehensive Medical Treatment of Complex Laryngeal Nerve Injuries in Thyroid Surgery
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 4, Issue 76
Abstract
Aim of the study. The key point of this research is studying the impact of different methods of medical treatment for patients with dysphonic syndrome after thyroid surgery due to intraoperative injury of the upper laryngeal nerve and complex injury of superior laryngeal nerve as well as the recurrent laryngeal nerve. Materials and methods. The research of various methods of medical treatment was performed on 47 patients after thyroid surgery with dysphonic manifestations. The patients were euthyroid; they were examined at all stages of the treatment by ENT specialist using video laryngoscope. The indices of acoustic voice analysis and evaluation of the voice handicap index, VHI‑30, were determined. The proposed method involves the application of a combination of two pharmacological agents: lysine and choline alfoscerate. At an early postoperative period in case of identifying dysphonic disorders the appropriate medical therapy was prescribed to patients. Identification of the indices of acoustic voice analysis, evaluation of the voice handicap index and fiber laryngoscopy aspect were carried out in groups of patients on the seventh and fourteenth day after the treatment order. Results. All the patients were divided into four groups. Conventional therapy was applied for the patients with diagnosed dysphonic syndrome in the first and the third groups. Patients in the second and the fourth groups received a combined therapy with lysine and cholini alfosceras. The study revealed that in the 2nd and the 4th groups of patients there was a significant change of indices with the trend to almost normal values in comparison with the 1st and the 3rd groups due to increased F0 and ΔF0. It is of great importance that the quality of life has improved, as evidenced by the decrease of VHI‑30. Conclusions. Using a combination of lysine and cholini alfosceras in postoperative dysphonia treatment indicates the effectiveness of this technique as compared to conventional drug therapy due to the improvement of mental and emotional states and functionality of the laryngeal voice apparatus. It can be used in complex treatment of paralyses and larynx paresis.
Authors and Affiliations
V. V. Voitenko, V. O. Palamarchuk
Keywords
Related Articles
- EP ID EP201822
- DOI -
- Views 50
- Downloads 0
Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2
The objective — to study the effectiveness of Vazonat (meldonium) in patients with diabetes mellitus (DM) type 2 in the comparative 12-week study. Materials and methods. The study involved 55 patients with DM type 2. Pa...
Adiponectin and Diabetes Mellitus Type 2 (Pathogenic Aspects as the Ground for Antidiabetic Pharmacotherapy Optimization)
The review deals with the role of adipose tissue dysfunction, primarily hypoadiponectinemia, in the development of diabetes mellitus type 2 and its cardiovascular complications. There are accentuated the benefits of oral...
Adrenal Incidentaloma: Diagnostics and Choice of Therapeutic Management
Taking into the consideration the widespread usage of modern instrumental methods of topical diagnosis, the choice of the management of patients with adrenal incidentalomas is a topical problem in current medicine. Both...
Features of pahogocytic activity of monocytes and neutrophils in patients with obesity and ankylosinig spondylitis depending on HLA B27 gene carrier
Background. Ankylosing spondylitis (AS) is a widespread pathology all over the world. The AS prevalence in different countries ranges from 0.2 to 2 %. Usually the disease debuts at the age of 20–40 years, men suffer from...
Use of Zinkit in Combination Treatment of Patients with Dwarfism
The article deals with the results of study of zinc content in children and adolescents with dwarfism due to somatotropic deficiency, and rationale for use of zinс-containing preparations (Zinkit, «Wörwag Pharma», German...